1.69
+0.09(+5.63%)
Currency In USD
| Previous Close | 1.6 |
| Open | 1.6 |
| Day High | 1.72 |
| Day Low | 1.57 |
| 52-Week High | 16.94 |
| 52-Week Low | 1.26 |
| Volume | 138,523 |
| Average Volume | 250,482 |
| Market Cap | 44.21M |
| PE | -0.2 |
| EPS | -8.52 |
| Moving Average 50 Days | 1.52 |
| Moving Average 200 Days | 2.93 |
| Change | 0.09 |
If you invested $1000 in Senti Biosciences, Inc. (SNTI) since IPO date, it would be worth $16.93 as of October 06, 2025 at a share price of $1.69. Whereas If you bought $1000 worth of Senti Biosciences, Inc. (SNTI) shares 3 years ago, it would be worth $25.92 as of October 06, 2025 at a share price of $1.69.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Senti Bio to Present at BioJapan
GlobeNewswire Inc.
2 hours ago
In-person presentation on Thursday, October 9th at 11:30 AM JSTSOUTH SAN FRANCISCO, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation ce
Senti Bio to Present at the MedInvest Biotech & Pharma Conference
GlobeNewswire Inc.
Sep 18, 2025 1:15 PM GMT
Live webcast presentation on Wednesday, September 24th at 9:55 AM PTSOUTH SAN FRANCISCO, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generat
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 1:05 PM GMT
Live webcast presentation with Co-Founder and CEO, Dr. Timothy Lu, on September 8th at 2:00 PM ETSOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology co